---
layout: default
title: T41B + BD10-2 + stim
parent: Projects
nav_order: 8
---

# T41B + BD10-2 + stim
{: .no_toc }

[View on GitHub](https://github.com/Longo-Lab/T41B_BD10-2_stim){: .btn .btn-primary }
[Counts dashboard](https://longo-stanford.shinyapps.io/count_T41B_BD10-2_stim/){: .btn .btn-secondary }
[DE dashboard](https://longo-stanford.shinyapps.io/de_T41B_BD10-2_stim/){: .btn .btn-secondary }
[Stimulation dashboard](https://longo-stanford.shinyapps.io/stim_T41B_BD10-2_stim/){: .btn .btn-secondary }

{: .info }
> - **Model**: T41B
> - **Age**: 16 month
> - **Drug**: BD10-2
> - **Treatment**: LTP
> - **Tissue**: Hippocampus
> - **Time since last dose**: 24h
> - **RNA-seq type**: Bulk

#### Table of contents
{: .no_toc .text-delta }

- TOC
{:toc}

---

## Publications

[![](/assets/images/t41b_bd10-2_stim_fig.png)](https://doi.org/10.1002/alz.13857)
{: .pub-img }

A TrkB and TrkC partial agonist restores deficits in synaptic function and promotes activity-dependent synaptic and microglial transcriptomic changes in a late-stage Alzheimer's mouse model
**Amira Latif-Hernandez, Tao Yang, Robert Raymond Butler III, Patricia Moran Losada, Paras S Minhas, Halle White, Kevin Chan Tran, Harry Liu, Danielle Simmons, Vanessa Langness, Katrin Andreasson, Tony Wyss-Coray, Frank M Longo**
_Alzheimer's & Dementia_ [20(7)4434-4460.](https://doi.org/10.1002/alz.13857) 
{: .pub-text }

## Methods

Code for analysis where available is in the github link above. Additional information regarding settings for trimming, mapping and differential expression are available on request.

